Quarterly report pursuant to Section 13 or 15(d)

8. RELATED PARTY TRANSACTIONS (Details)

v3.19.1
8. RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Sale and purchase of plasma      
Product revenue $ 0 $ 2,328,291  
Purchases 160,489 195,018  
License revenue 35,708 35,708  
Interest expense 225,000 $ 225,000  
Accounts receivable 0   $ 961,145
Prepaid expenses and other current assets 0   0
Accounts payable 296,362   2,010,774
Accrued expenses 24,049   10,659
Note payable, net of discount 14,882,337   14,874,184
Accrued interest 290,000   65,000
Deferred revenue $ 2,511,491   $ 2,547,199